Haggi Mazeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Haggi Mazeh has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
Nahum Beglaibter
Department of Surgery, Hadassah-Hebrew University Medical Center, Mount Scopus, 91240, Jerusalem, Israel
5 shared publicationsRonit Grinbaum
Hebrew Univ Jerusalem, Fac Med, Hadassah Med Ctr, Dept Surg, Jerusalem, Israel
5 shared publications- Abbas Al-Kurd
Department of Surgery, Hadassah-Hebrew University Medical Center, Mount Scopus, 91240, Jerusalem, Israel.
4 shared publications Ahmed Eid
Department of Surgery, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
4 shared publicationsHerbert R. Freund
Department of General Surgery, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem, Israel
4 shared publications- Ido Mizrahi
Department of General Surgery, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, P.O. Box 12000, Jerusalem 91120, Israel
4 shared publications
Latest Publications
- Open Access
- 18 October 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5256-5263
High Incidence of Benign Perianal Disorders After Sleeve Gastrectomy and One Anastomosis Gastric Bypass
Aim: Bariatric surgery may alter bowel habits, potentially leading to new-onset benign perianal disorders (NOPD). This study aimed to assess the incidence and identify potential risk factors of NOPD following vertical sleeve gastrectomy (VSG) and one anastomosis (mini) gastric bypass (OAGB). Methods: We conducted a retrospective cross-sectional, single-center study using retrospective analysis of prospectively collected data. All patients who underwent VSG or OAGB between 2015–2018 were considered. NOPD diagnoses were based on physical examinations and a standardized phone questionnaire assessing past and present perianal symptoms. Results: Of 540 eligible patients, 313 participated (150 VSG, 163 OAGB). Among 264 patients without prior perianal disorders, 96 (36.4%) developed NOPD postoperatively—29.6% in the VSG group vs. 42.4% in the OAGB group ( p = 0.04). The most common conditions were hemorrhoidal disease (24.2%), fissures (12.8%), and abscesses/fistulas (3%). Surgical treatment was required in 17.7% (17/96) of affected patients. Increased bowel movement frequency was more common after OAGB than VSG (57.7% vs. 11.7%, p < 0.001). OAGB, younger age, and altered bowel habits were associated with higher NOPD risk. Forty-nine patients (15.7%) reported preexisting perianal disorders, 26.5% of whom experienced worsening symptoms. Overall, 86% of patients were unaware of the link between bariatric surgery and NOPD, and 15% indicated they would not recommend surgery due to these symptoms. Conclusion: NOPD are relatively common after bariatric surgery, particularly OAGB. Patients—especially those with identified risk factors—should be counselled regarding this potential complication during the preoperative decision-making process.
- 18 October 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (12) , 5256-5263
Open AccessHigh Incidence of Benign Perianal Disorders After Sleeve Gastrectomy and One Anastomosis Gastric Bypass
Aim: Bariatric surgery may alter bowel habits, potentially leading to new-onset benign perianal disorders (NOPD). This study aimed to assess the incidence and identify potential risk factors of NOPD following vertical sleeve gastrectomy (VSG) and one anastomosis (mini) gastric bypass (OAGB). Methods: We conducted a retrospective cross-sectional, single-center study using retrospective analysis of prospectively collected data. All patients who underwent VSG or OAGB between 2015–2018 were considered. NOPD diagnoses were based on physical examinations and a standardized phone questionnaire assessing past and present perianal symptoms. Results: Of 540 eligible patients, 313 participated (150 VSG, 163 OAGB). Among 264 patients without prior perianal disorders, 96 (36.4%) developed NOPD postoperatively—29.6% in the VSG group vs. 42.4% in the OAGB group ( p = 0.04). The most common conditions were hemorrhoidal disease (24.2%), fissures (12.8%), and abscesses/fistulas (3%). Surgical treatment was required in 17.7% (17/96) of affected patients. Increased bowel movement frequency was more common after OAGB than VSG (57.7% vs. 11.7%, p < 0.001). OAGB, younger age, and altered bowel habits were associated with higher NOPD risk. Forty-nine patients (15.7%) reported preexisting perianal disorders, 26.5% of whom experienced worsening symptoms. Overall, 86% of patients were unaware of the link between bariatric surgery and NOPD, and 15% indicated they would not recommend surgery due to these symptoms. Conclusion: NOPD are relatively common after bariatric surgery, particularly OAGB. Patients—especially those with identified risk factors—should be counselled regarding this potential complication during the preoperative decision-making process.
- 28 March 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (5) , 1612-1619
The Effect of Preoperative Single-Dose Tranexamic Acid on Bleeding and Thromboembolic Events Following Bariatric Surgery
Background Intravenous tranexamic acid (TXA) has been shown to reduce perioperative blood loss and transfusion needs in various surgeries. However, its effectiveness in minimizing these complications during metabolic bariatric surgery remains unclear. This study aimed to determine whether a single prophylactic dose of intravenous TXA administered before metabolic bariatric surgery reduces the risk of perioperative hemorrhage. Methods A retrospective analysis was conducted on patients who underwent metabolic bariatric surgery at our institute from 2019 to 2022, with routine TXA administration starting in 2021. A comparison was made between the TXA and non-TXA groups, with all surgeries performed by a single surgical team. Results A total of 901 patients were included, with 560 (62.2%) in the non-TXA group and 341 (37.8%) in the TXA group. There were no significant differences between groups in age, sex, or preoperative BMI, although a higher proportion of post-2021 patients underwent gastric bypass. No significant differences were observed in the percentage of patients with bloody surgical drains (4.2% vs. 4.9%, p = 0.662), transfusion need (1.5% vs. 1.6%, p = 1), re-operations for bleeding (3.2% vs. 2.3%, p = 0.582), or postoperative thromboembolic events (0.2% vs. 0%, p = 1.0). Conclusions A single dose of intravenous TXA did not reduce postoperative bleeding in bariatric patients, nor were there significant differences in thromboembolic events or mortality between groups. Further randomized controlled trials are needed to confirm or refute TXA’s effectiveness in reducing this potentially life-threatening complication.
- 28 March 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (5) , 1612-1619
The Effect of Preoperative Single-Dose Tranexamic Acid on Bleeding and Thromboembolic Events Following Bariatric Surgery
Background Intravenous tranexamic acid (TXA) has been shown to reduce perioperative blood loss and transfusion needs in various surgeries. However, its effectiveness in minimizing these complications during metabolic bariatric surgery remains unclear. This study aimed to determine whether a single prophylactic dose of intravenous TXA administered before metabolic bariatric surgery reduces the risk of perioperative hemorrhage. Methods A retrospective analysis was conducted on patients who underwent metabolic bariatric surgery at our institute from 2019 to 2022, with routine TXA administration starting in 2021. A comparison was made between the TXA and non-TXA groups, with all surgeries performed by a single surgical team. Results A total of 901 patients were included, with 560 (62.2%) in the non-TXA group and 341 (37.8%) in the TXA group. There were no significant differences between groups in age, sex, or preoperative BMI, although a higher proportion of post-2021 patients underwent gastric bypass. No significant differences were observed in the percentage of patients with bloody surgical drains (4.2% vs. 4.9%, p = 0.662), transfusion need (1.5% vs. 1.6%, p = 1), re-operations for bleeding (3.2% vs. 2.3%, p = 0.582), or postoperative thromboembolic events (0.2% vs. 0%, p = 1.0). Conclusions A single dose of intravenous TXA did not reduce postoperative bleeding in bariatric patients, nor were there significant differences in thromboembolic events or mortality between groups. Further randomized controlled trials are needed to confirm or refute TXA’s effectiveness in reducing this potentially life-threatening complication.
- 1 August 2023
- Vol. 25 (8) , 538-541
Incidental Gastric Signet Ring Cell Carcinoma: A Call for an Aggressive Approach
Background: Signet ring cell carcinoma (SRCC) is classified as an undifferentiated gastric carcinoma with poor prognosis. Early SRCCs are associated with improved prognosis.Objectives: To describe the outcomes of incidental SRCC.Methods: In this case series, 900 medical charts of patients with SRCC were screened to identify patients with incidental SRCC, defined as diagnosed in random, non-focal-lesion -targeted biopsies.Results: Six patients were diagnosed with incidental SRCC and underwent gastrectomy. The final pathology of five patients revealed one or more small foci of early SRCC without lymphovascular invasion. Only one patient had no evidence of malignancy. The median follow-up after surgery was 4.2 years (50 months, range 37-90 months). No deaths or recurrences were recorded during the follow-up period. These results resemble the reported survival rate for early SRCC.Conclusions: An aggressive surgical approach in incidental gastric SRCC patients is recommended, as they have a chance for long-term survival.
- 1 August 2023
- Vol. 25 (8) , 538-541
Incidental Gastric Signet Ring Cell Carcinoma: A Call for an Aggressive Approach
Background: Signet ring cell carcinoma (SRCC) is classified as an undifferentiated gastric carcinoma with poor prognosis. Early SRCCs are associated with improved prognosis.Objectives: To describe the outcomes of incidental SRCC.Methods: In this case series, 900 medical charts of patients with SRCC were screened to identify patients with incidental SRCC, defined as diagnosed in random, non-focal-lesion -targeted biopsies.Results: Six patients were diagnosed with incidental SRCC and underwent gastrectomy. The final pathology of five patients revealed one or more small foci of early SRCC without lymphovascular invasion. Only one patient had no evidence of malignancy. The median follow-up after surgery was 4.2 years (50 months, range 37-90 months). No deaths or recurrences were recorded during the follow-up period. These results resemble the reported survival rate for early SRCC.Conclusions: An aggressive surgical approach in incidental gastric SRCC patients is recommended, as they have a chance for long-term survival.
- Open Access
- 27 April 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Surgery
- Vol. 15 (4) , 566-577
Surgical aspects of small intestinal neuroendocrine tumors
Surgical aspects of small intestinal neuroendocrine tumors
- 27 April 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Surgery
- Vol. 15 (4) , 566-577
Open AccessSurgical aspects of small intestinal neuroendocrine tumors
Surgical aspects of small intestinal neuroendocrine tumors
- 23 January 2023
- Published by Wiley in World Journal of Surgery
- Vol. 47 (4) , 985-994
Deliberate Compensated Vasoplegia–A Novel Pharmaceutical Approach for Controlling Blood Pressure During Surgery for Pheochromocytoma
Background: The most dreaded adverse event of pheochromocytoma surgery is operative severe blood pressure fluctuations. Preoperative protocols with alpha‐blockade have achieved controversial results. No study to date evaluated the use of operative protocols in pheochromocytoma patients. Deliberated compensated vasoplegia (DCV) is a novel pharmaceutical regimen developed at our institution to decrease severe hypertensive events. The aim of this study is to compare outcomes of pheochromocytoma resection with and without DCV protocol. Methods: A retrospective analysis of all pheochromocytoma resections between the years 2012 and 2021 was performed. Resections performed with and without DCV protocol were compared. The primary outcome measured was the incidence of severe hypertension (MAP > 150 mmHg) during surgery. Secondary outcomes included other abnormal blood pressure measurements as well as perioperative data and complications.Results: A total of 41 resections were included, 21 performed under DCV protocol, and 20 without the protocol. Analysis demonstrated no significant difference in preoperative parameters including tumor size, catecholamine levels, and preoperative alpha‐blockade protocol. The use of DCV protocol resulted in significant decrease in severe hypertension incidence from 1.95 ± 3.6 to 0.03 ± 0.13 events/h, p = 0.008. Application of the DCV protocol was not associated with any other adverse events.Conclusions: This study suggests that DCV anesthesia protocol significantly decreases the incidence of severe hypertensive episodes during pheochromocytoma resection. This is the first study that describes a highly effective protocol for controlling hypertension in pheochromocytoma patients.
- 23 January 2023
- Published by Wiley in World Journal of Surgery
- Vol. 47 (4) , 985-994
Deliberate Compensated Vasoplegia–A Novel Pharmaceutical Approach for Controlling Blood Pressure During Surgery for Pheochromocytoma
Background: The most dreaded adverse event of pheochromocytoma surgery is operative severe blood pressure fluctuations. Preoperative protocols with alpha‐blockade have achieved controversial results. No study to date evaluated the use of operative protocols in pheochromocytoma patients. Deliberated compensated vasoplegia (DCV) is a novel pharmaceutical regimen developed at our institution to decrease severe hypertensive events. The aim of this study is to compare outcomes of pheochromocytoma resection with and without DCV protocol. Methods: A retrospective analysis of all pheochromocytoma resections between the years 2012 and 2021 was performed. Resections performed with and without DCV protocol were compared. The primary outcome measured was the incidence of severe hypertension (MAP > 150 mmHg) during surgery. Secondary outcomes included other abnormal blood pressure measurements as well as perioperative data and complications.Results: A total of 41 resections were included, 21 performed under DCV protocol, and 20 without the protocol. Analysis demonstrated no significant difference in preoperative parameters including tumor size, catecholamine levels, and preoperative alpha‐blockade protocol. The use of DCV protocol resulted in significant decrease in severe hypertension incidence from 1.95 ± 3.6 to 0.03 ± 0.13 events/h, p = 0.008. Application of the DCV protocol was not associated with any other adverse events.Conclusions: This study suggests that DCV anesthesia protocol significantly decreases the incidence of severe hypertensive episodes during pheochromocytoma resection. This is the first study that describes a highly effective protocol for controlling hypertension in pheochromocytoma patients.
- 11 April 2022
- Published by Wiley in World Journal of Surgery
- Vol. 46 (8) , 1908-1914
Minimally Invasive Parathyroidectomy: Can Intraoperative Parathyroid Hormone Monitoring be Omitted?
Background Intraoperative PTH (ioPTH) monitoring has become widely accepted in the era of minimally invasive parathyroidectomy (MIP). The purpose of this study was to evaluate the need for ioPTH during parathyroidectomy in patients with positive preoperative imaging. Methods The charts of patients who underwent parathyroidectomy at three tertiary centers between the years 2012 and 2021 were retrospectively reviewed. Patients were defined as MIP candidates with either concordant preoperative imaging or a single positive imaging. Patients with negative or discordant imaging, concomitant thyroidectomy, or previous neck surgery were excluded. Results Of a total of 1013 patients who underwent parathyroidectomy, 535 (52.8%) were defined as MIP candidates and were included in the statistical analysis. Surgical success was achieved in all patients. A single adenoma that corresponded to the preoperative imaging was identified and resected in 517 (93.8%) patients. In only 18 (3.3%) patients, the ioPTH correctly changed the operative management where additional pathologic glands were identified and excised. Patients with additional lesions were significantly more likely to have decreased index adenoma size as indicated either by preoperative imaging or by intraoperative findings (15.5 ± 6.6 vs. 8.3 ± 2.5 mm, p < 0.001). None of the patients with an adenoma size greater than 13 mm had an additional pathologic gland. Conclusions Our findings suggest that the routine use of ioPTH in MIP candidates may be omitted in patients with an index adenoma greater than 13 mm, even with only a single positive preoperative imaging study, without compromising surgical success.
- 11 April 2022
- Published by Wiley in World Journal of Surgery
- Vol. 46 (8) , 1908-1914
Minimally Invasive Parathyroidectomy: Can Intraoperative Parathyroid Hormone Monitoring be Omitted?
Background Intraoperative PTH (ioPTH) monitoring has become widely accepted in the era of minimally invasive parathyroidectomy (MIP). The purpose of this study was to evaluate the need for ioPTH during parathyroidectomy in patients with positive preoperative imaging. Methods The charts of patients who underwent parathyroidectomy at three tertiary centers between the years 2012 and 2021 were retrospectively reviewed. Patients were defined as MIP candidates with either concordant preoperative imaging or a single positive imaging. Patients with negative or discordant imaging, concomitant thyroidectomy, or previous neck surgery were excluded. Results Of a total of 1013 patients who underwent parathyroidectomy, 535 (52.8%) were defined as MIP candidates and were included in the statistical analysis. Surgical success was achieved in all patients. A single adenoma that corresponded to the preoperative imaging was identified and resected in 517 (93.8%) patients. In only 18 (3.3%) patients, the ioPTH correctly changed the operative management where additional pathologic glands were identified and excised. Patients with additional lesions were significantly more likely to have decreased index adenoma size as indicated either by preoperative imaging or by intraoperative findings (15.5 ± 6.6 vs. 8.3 ± 2.5 mm, p < 0.001). None of the patients with an adenoma size greater than 13 mm had an additional pathologic gland. Conclusions Our findings suggest that the routine use of ioPTH in MIP candidates may be omitted in patients with an index adenoma greater than 13 mm, even with only a single positive preoperative imaging study, without compromising surgical success.
- Open Access
- 1 January 2021
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 101 (2) , 79-84
Adrenal ganglioneuroma resected for suspicious malignancy: multicenter review of 25 cases and review of the literature
Zilberman DE, et al. Ann Surg Treat Res. 2021 Aug;101(2):79-84. https://doi.org/10.4174/astr.2021.101.2.79
- 1 January 2021
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 101 (2) , 79-84
Open AccessAdrenal ganglioneuroma resected for suspicious malignancy: multicenter review of 25 cases and review of the literature
Zilberman DE, et al. Ann Surg Treat Res. 2021 Aug;101(2):79-84. https://doi.org/10.4174/astr.2021.101.2.79
- 1 November 2020
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (11) , 2023-2028
The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study
- 1 November 2020
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 46 (11) , 2023-2028
The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study
- 1 February 2020
- Published by Wiley in World Journal of Surgery
- Vol. 44 (2) , 346-347
The Role of Tumor and Lymph Node Size and Extension in Papillary Thyroid Cancer Staging
- 1 February 2020
- Published by Wiley in World Journal of Surgery
- Vol. 44 (2) , 346-347
The Role of Tumor and Lymph Node Size and Extension in Papillary Thyroid Cancer Staging
- Open Access
- 1 September 2019
- Published by Elsevier in AACE Clinical Case Reports
- Vol. 5 (5) , e321-e325
A Retroperitoneal Seminoma with Entrapped Nerve Ganglion Masquerading as a Paraganglioma
- 1 September 2019
- Published by Elsevier in AACE Clinical Case Reports
- Vol. 5 (5) , e321-e325
Open AccessA Retroperitoneal Seminoma with Entrapped Nerve Ganglion Masquerading as a Paraganglioma